InvestorsHub Logo
Followers 18
Posts 1421
Boards Moderated 0
Alias Born 11/01/2018

Re: None

Monday, 01/03/2022 8:24:50 PM

Monday, January 03, 2022 8:24:50 PM

Post# of 458338
I have been here for five to six years like so many others. I feel lucky I got in early. ( Thanks Bourbon) I believe in this science after all the information for this period of time. The only thing that troubles me is why haven't the markets responded with a close to fair valuation. Yes, I know we didn't IPO and all that. But when this information came out seven months ago it should have taken us to a 3 to 5 billion dollar MC. imo

Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Parkinson’s Disease Dementia.

https://finance.yahoo.com/news/anavex-life-sciences-announces-anavex-110000682.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News